TGF‐β as a driver of fibrosis: physiological roles and therapeutic opportunities

EH Budi, JR Schaub, M Decaris, S Turner… - The Journal of …, 2021 - Wiley Online Library
Many chronic diseases are marked by fibrosis, which is defined by an abundance of
activated fibroblasts and excessive deposition of extracellular matrix, resulting in loss of …

Backstage players of fibrosis: NOX4, mTOR, HDAC, and S1P; companions of TGF-β

AP Jiménez-Uribe, T Gomez-Sierra, OE Aparicio-Trejo… - Cellular …, 2021 - Elsevier
The fibrotic process could be easily defined as a pathological excess of extracellular matrix
deposition, leading to disruption of tissue architecture and eventually loss of function; …

[HTML][HTML] Mitophagy-dependent macrophage reprogramming protects against kidney fibrosis

D Bhatia, KP Chung, K Nakahira, E Patino, MC Rice… - JCI insight, 2019 - ncbi.nlm.nih.gov
Mitophagy, by maintaining mitochondrial quality control, plays a key role in maintaining
kidney function and is impaired in pathologic states. Macrophages are well known for their …

Anti-fibrosis activity of quercetin attenuates rabbit tracheal stenosis via the TGF-β/AKT/mTOR signaling pathway

Y Xiao, L Zhou, T Zhang, C Qin, P Wei, L Luo, L Luo… - Life sciences, 2020 - Elsevier
Aims This study aimed to explore the possible mechanism of trauma-induced
laryngotracheal stenosis and potential protective and therapeutic efficacy of quercetin on …

Crohn's disease-associated AIEC inhibiting intestinal epithelial cell-derived exosomal let-7b expression regulates macrophage polarization to exacerbate intestinal …

Y Xu, W Qian, L Huang, W Wen, Y Li, F Guo, Z Zhu… - Gut …, 2023 - Taylor & Francis
The interaction between adherent-invasive Escherichia coli (AIEC) and intestinal
macrophages is implicated in the pathogenesis of Crohn's disease (CD). However, its role in …

TGF-β1 signaling: immune dynamics of chronic kidney diseases

PCT Tang, ASW Chan, CB Zhang… - Frontiers in …, 2021 - frontiersin.org
Chronic kidney disease (CKD) is a major cause of morbidity and mortality worldwide,
imposing a great burden on the healthcare system. Regrettably, effective CKD therapeutic …

Yap/Taz mediates mTORC2-stimulated fibroblast activation and kidney fibrosis

Y Gui, J Li, Q Lu, Y Feng, M Wang, W He, J Yang… - Journal of Biological …, 2018 - ASBMB
Our previously published study demonstrated that mammalian target of rapamycin complex
2 (mTORC2) signaling mediates TGFβ1-induced fibroblast activation. However, the …

[PDF][PDF] The role of dexmedetomidine in immune tissue and inflammatory diseases: a narrative review.

R Chen, XK Dou, MS Dai, Y Sun… - European Review for …, 2022 - europeanreview.org
OBJECTIVE: Adrenergic receptors belong to the G protein-coupled receptor family and are
one of the important targets of modern drug therapy. Dexmedetomidine (DEX) is a highly …

mTOR signaling in immune cells and its implications for cancer immunotherapy

H Zeng - Cancer letters, 2017 - Elsevier
The realization that cellular metabolism dictates immune cell development, differentiation
and function affords metabolic intervention as a potential venue for cancer immunotherapy …

mTOR signaling in kidney diseases

Y Gui, C Dai - Kidney360, 2020 - journals.lww.com
The mammalian target of rapamycin (mTOR), a serine/threonine protein kinase, is crucial in
regulating cell growth, metabolism, proliferation, and survival. Under physiologic conditions …